- Home
- TRTX vs KURA Comparison
TRTX vs KURA Comparison
Compare TRTX & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRTX
- KURA
- Stock Information
- Founded
- TRTX 2014
- KURA 2014
- Country
- TRTX United States
- KURA United States
- Employees
- TRTX N/A
- KURA N/A
- Industry
- TRTX Real Estate Investment Trusts
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRTX Real Estate
- KURA Health Care
- Exchange
- TRTX Nasdaq
- KURA Nasdaq
- Market Cap
- TRTX 738.0M
- KURA 713.5M
- IPO Year
- TRTX 2017
- KURA N/A
- Fundamental
- Price
- TRTX $9.36
- KURA $8.37
- Analyst Decision
- TRTX Buy
- KURA Buy
- Analyst Count
- TRTX 3
- KURA 14
- Target Price
- TRTX $9.50
- KURA $24.45
- AVG Volume (30 Days)
- TRTX 659.0K
- KURA 1.7M
- Earning Date
- TRTX 10-28-2025
- KURA 11-06-2025
- Dividend Yield
- TRTX 10.35%
- KURA N/A
- EPS Growth
- TRTX N/A
- KURA N/A
- EPS
- TRTX 0.65
- KURA N/A
- Revenue
- TRTX $138,587,000.00
- KURA $83,279,000.00
- Revenue This Year
- TRTX N/A
- KURA $60.25
- Revenue Next Year
- TRTX $6.77
- KURA $155.10
- P/E Ratio
- TRTX $14.27
- KURA N/A
- Revenue Growth
- TRTX 216.02
- KURA N/A
- 52 Week Low
- TRTX $6.47
- KURA $5.41
- 52 Week High
- TRTX $9.85
- KURA $21.40
- Technical
- Relative Strength Index (RSI)
- TRTX 54.86
- KURA 59.66
- Support Level
- TRTX $9.10
- KURA $8.08
- Resistance Level
- TRTX $9.51
- KURA $8.58
- Average True Range (ATR)
- TRTX 0.18
- KURA 0.50
- MACD
- TRTX -0.05
- KURA -0.04
- Stochastic Oscillator
- TRTX 32.67
- KURA 57.60
About TRTX TPG RE Finance Trust Inc.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.